What investigations are required for a patient with suspected multiple sclerosis based on clinical findings and MRI before initiating disease-modifying therapy?

Investigations for Suspected Multiple Sclerosis Before Treatment

Before initiating disease-modifying therapy in suspected MS, you must obtain: (1) brain and whole spinal cord MRI with gadolinium, (2) CSF analysis for oligoclonal bands, and (3) serum testing for aquaporin-4 and MOG antibodies to exclude mimics 1, 2.

Essential Imaging Protocol

Initial MRI Requirements

The cornerstone investigation is comprehensive MRI imaging 1:

• Brain MRI with gadolinium contrast - This is mandatory at baseline to detect enhancing lesions (indicating active inflammation) and establish dissemination in time when both enhancing and non-enhancing lesions coexist 1
• Whole spinal cord MRI (cervical, thoracic, lumbar) - Required to demonstrate dissemination in space and exclude alternative diagnoses like spinal stenosis or tumors 1, 2
• Susceptibility-sensitive imaging - Now recommended routinely to identify the central vein sign and paramagnetic rim lesions, which are highly specific for MS 1

The 2024 MAGNIMS-CMSC-NAIMS consensus emphasizes that typical lesions in at least four anatomical locations (periventricular, cortical/juxtacortical, infratentorial, spinal cord) allow MS diagnosis without additional testing 1. However, if fewer than four locations show lesions, you need supplementary evidence.

Technical Specifications

Use 3D acquisitions with isotropic voxels (≤1 mm dimensions) or 2D slices maximum 3 mm thick with no gaps 2. The core sequences include:

• T2-weighted FLAIR (preferably 3D) for lesion identification
• T1 post-gadolinium for active inflammation
• Susceptibility-weighted imaging for central vein sign 1

Critical Laboratory Investigations

CSF Analysis

Lumbar puncture is essential when MRI shows lesions in fewer than four typical locations 1. CSF findings supporting MS diagnosis include:

• Oligoclonal bands (present in ~95% of MS patients) 3, 4
• Elevated IgG index
• Mild lymphocytic pleocytosis

CSF analysis serves dual purposes: supporting MS diagnosis and excluding infectious/inflammatory mimics 5.

Antibody Testing to Exclude Mimics

This is a critical step that prevents devastating misdiagnosis 1, 2:

• Aquaporin-4 IgG antibodies - Mandatory to exclude neuromyelitis optica spectrum disorder (NMOSD). Treating NMOSD with standard MS therapies can worsen outcomes 6
• MOG-IgG antibodies - Essential to identify MOG antibody disease, which has different prognosis and treatment 1, 2

The 2024 consensus explicitly states that excluding these antibody-mediated diseases is a key diagnostic step before applying MS criteria 1.

Additional Investigations Based on Clinical Context

When to Consider Evoked Potentials

Visual evoked potentials can demonstrate subclinical optic nerve involvement, helping establish dissemination in space when MRI findings are limited 5. However, with modern MRI protocols, evoked potentials play a diminished role.

Fat-Suppressed Optic Nerve MRI

Consider this in atypical presentations to rule out alternative diagnoses, particularly when distinguishing MS from NMOSD or MOG disease 2.

Common Pitfalls to Avoid

Age-related considerations: In patients >50 years or with vascular risk factors, apply more stringent criteria—require a higher number of periventricular lesions abutting the lateral ventricles to avoid misdiagnosing vascular disease as MS 2.

Red flags requiring additional workup 2:

• Persistent gadolinium enhancement >3 months (suggests tumor or infection)
• Lesions with significant mass effect (consider biopsy for tumefactive lesions)
• Meningeal enhancement (suggests infection, sarcoidosis, or malignancy)
• Atypical lesion patterns (longitudinally extensive spinal cord lesions suggest NMOSD)

Quality standards: MRI must be performed on ≥1.5T scanners with minimal artifacts. Poor quality imaging leads to misdiagnosis 2.

Algorithm for Investigation Sequence

1. Obtain brain and whole spinal cord MRI with gadolinium - This is your first-line investigation
2. Send serum for aquaporin-4 and MOG antibodies - Do this immediately, before considering treatment
3. Perform lumbar puncture if:
   • MRI shows lesions in <4 typical locations
   • Clinical presentation is atypical
   • Patient age >50 years
   • Need to exclude infectious/inflammatory mimics
4. Consider brain biopsy only if imaging shows atypical features (mass effect, persistent enhancement >3 months) that cannot be explained by MS 7, 8

Timing Considerations

The 2024 McDonald criteria allow MS diagnosis at first clinical event if MRI demonstrates lesions in ≥4 typical locations, enabling earlier treatment initiation 1. This represents a shift toward aggressive early intervention, as high-efficacy therapies started early provide the best opportunity to influence disease course 9.

Do not delay antibody testing or CSF analysis if clinically indicated—misdiagnosing NMOSD or MOG disease as MS and starting inappropriate therapy can cause severe harm 1, 6.